Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT88390Aexternal-prioritypatent/ATA39088A/de
Application filed by Chemisch Pharmazeutische Forschungsgesellschaft M.B.H.filedCriticalChemisch Pharmazeutische Forschungsgesellschaft M.B.H.
Publication of MD266B1publicationCriticalpatent/MD266B1/ro
Publication of MD266C2publicationCriticalpatent/MD266C2/ro
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur
(AREA)
Abstract
Invenţia se referă la substanţele heterociclice, şi în special, la obţinerea derivaţilor 5-haloindienoizotiazol-3(2H)-on-1,1dioxizilor sau a sărurilor lor acide aditive farmaceutic suportabile cu formula:în care R reprezintă haloid cu activitate anxiolitică, ceea ce poate fi utilizat în medicină. Scopul invenţiei constă în obţinerea substanţelor noi mai active din clasa indicată. Sinteza se realizează prin reacţia 1-(2-pirimidinil) piperazinei cu compusul cu formula:în care X reprezintă haloid, în mediul dimetilformamidei absolute la temperatura de 60°C timp de 45 minute, eliminând ulterior produsul cu destinaţie specială în stare liberă sau în stare liberă sau în stare de sare necesară. Substanţele noi sunt puţin toxice (mai mult de 2000 mg/kg) şi au o acţiune puternică antiolitică.
MD94-0300A1988-02-181994-09-14Procedeu de obţinere a derivaţilor 5-haloidtienoizotiazol-3(2H)-on-1,1-dioxizilor
MD266C2
(ro)
Basisch substituierte thienoisothiazol-3(2h)-on-1,1-dioxide und ihre pharmazeutisch vertraeglichen salze, verfahren zu ihrer herstellung und ihre verwendung
Process for producing 3-piperidinole-indazole derivatives and pharmaceutical preparations having effect against high blood pressure containing these compounds as active substance
Process for producing ether derivatives and thioether derivatives, as well as pharmaceutical compositions comprising these compounds as active ingredient
Method for the synthesis of 1-cyclopropyl-6-fluoro-1,4 dihydro-4-oxo-7-chloro-quinoline-3-carboxylic acid as basis for the preparation of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-piperazine-quinoline-3-carboxylic acids
Process for producing cardio-protective and suitable for treating ischemic illnesses pharmaceutical compositions containing nitriferous heterocyclic compounds as active agent as well as for producing the active agents